• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于临床 I 期非小细胞肺癌患者区域淋巴结转移术中预测的数学模型。

Mathematical models for intraoperative prediction of metastasis to regional lymph nodes in patients with clinical stage I non-small cell lung cancer.

机构信息

Department of Thoracic and Cardiovascular Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Medicine (Baltimore). 2022 Oct 21;101(42):e30362. doi: 10.1097/MD.0000000000030362.

DOI:10.1097/MD.0000000000030362
PMID:36281188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9592279/
Abstract

It remains challenging to determine the regions of metastasis to lymph nodes during operation for clinical stage I non-small cell lung cancer (NSCLC). This study aimed to establish intraoperative mathematical models with nomograms for predicting the hilar-intrapulmonary node metastasis (HNM) and the mediastinal node metastasis (MNM) in patients with clinical stage I NSCLC. The clinicopathological variables of 585 patients in a derivation cohort who underwent thoracoscopic lobectomy with complete lymph node dissection were retrospectively analyzed for their association with the HNM or the MNM. After analyzing the variables, we developed multivariable logistic models with nomograms to estimate the risk of lymph node metastasis in different regions. The predictive efficacy was then validated in a validation cohort of 418 patients. It was confirmed that carcinoembryonic antigen (>5.75 ng/mL), CYFRA211 (>2.85 ng/mL), the maximum diameter of tumor (>2.75 cm), tumor differentiation (grade III), bronchial mucosa and cartilage invasion, and vascular invasion were predictors of HNM, and carcinoembryonic antigen (>8.25 ng/mL), CYFRA211 (>2.95 ng/mL), the maximum diameter of tumor (>2.75 cm), tumor differentiation (grade III), bronchial mucosa and cartilage invasion, vascular invasion, and visceral pleural invasion were predictors of MNM. The validation of the prediction models based on the above results demonstrated good discriminatory power. Our predictive models are helpful in the decision-making process of specific therapeutic strategies for the regional lymph node metastasis in patients with clinical stage I NSCLC.

摘要

在临床 I 期非小细胞肺癌(NSCLC)手术中,确定淋巴结转移区域仍然具有挑战性。本研究旨在建立用于预测临床 I 期 NSCLC 患者肺门-肺内淋巴结转移(HNM)和纵隔淋巴结转移(MNM)的术中数学模型和列线图。回顾性分析了 585 例接受电视胸腔镜肺叶切除术和完全淋巴结清扫术的患者的临床病理变量与 HNM 或 MNM 的相关性。在分析了这些变量后,我们使用列线图建立了多变量逻辑模型来估计不同区域淋巴结转移的风险。然后在 418 例验证队列中验证了预测效能。结果证实癌胚抗原(>5.75ng/mL)、细胞角蛋白 19 片段(>2.85ng/mL)、肿瘤最大直径(>2.75cm)、肿瘤分化程度(III 级)、支气管黏膜和软骨侵犯、血管侵犯是 HNM 的预测因子,癌胚抗原(>8.25ng/mL)、细胞角蛋白 19 片段(>2.95ng/mL)、肿瘤最大直径(>2.75cm)、肿瘤分化程度(III 级)、支气管黏膜和软骨侵犯、血管侵犯和内脏胸膜侵犯是 MNM 的预测因子。基于上述结果验证预测模型显示出良好的判别能力。我们的预测模型有助于为临床 I 期 NSCLC 患者的区域淋巴结转移制定特定的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/4011d1ebe4ea/medi-101-e30362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/b44e7f90b6e7/medi-101-e30362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/5d4445953d21/medi-101-e30362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/4011d1ebe4ea/medi-101-e30362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/b44e7f90b6e7/medi-101-e30362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/5d4445953d21/medi-101-e30362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2da/9592279/4011d1ebe4ea/medi-101-e30362-g003.jpg

相似文献

1
Mathematical models for intraoperative prediction of metastasis to regional lymph nodes in patients with clinical stage I non-small cell lung cancer.用于临床 I 期非小细胞肺癌患者区域淋巴结转移术中预测的数学模型。
Medicine (Baltimore). 2022 Oct 21;101(42):e30362. doi: 10.1097/MD.0000000000030362.
2
Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer.术中诊断为Ⅰ期非小细胞肺癌患者不同区域淋巴结转移的临床病理预测因素。
BMC Cancer. 2019 May 14;19(1):444. doi: 10.1186/s12885-019-5632-2.
3
[Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].[非小细胞肺癌患者纵隔淋巴结转移的危险因素分析及术前纵隔镜检查策略]
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):456-9.
4
A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.利用术中诊断为Ⅰ期非小细胞肺癌患者的病理特征预测淋巴结转移的模型
BMC Cancer. 2017 Apr 13;17(1):267. doi: 10.1186/s12885-017-3273-x.
5
Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.浸润性成分大小为 3cm 或更小的外周型非小细胞肺癌隐匿性淋巴结转移的危险因素。
World J Surg. 2020 May;44(5):1658-1665. doi: 10.1007/s00268-019-05365-5.
6
A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.直径 2cm 或以下切除的非小细胞肺癌的临床病理研究:预后评估。
Med Oncol. 2011 Dec;28(4):1441-6. doi: 10.1007/s12032-010-9632-y. Epub 2010 Jul 27.
7
Selective Mediastinal Lymph Node Dissection Strategy for Clinical T1N0 Invasive Lung Cancer: A Prospective, Multicenter, Clinical Trial.临床 T1N0 期浸润性肺癌选择性纵隔淋巴结清扫策略:一项前瞻性、多中心临床试验。
J Thorac Oncol. 2023 Jul;18(7):931-939. doi: 10.1016/j.jtho.2023.02.010. Epub 2023 Feb 24.
8
Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.位于左舌叶的非小细胞肺癌的临床病理特征及淋巴结转移途径
Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):791-6. doi: 10.1093/icvts/ivv062. Epub 2015 Mar 24.
9
[Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].[临床I a期非小细胞肺癌淋巴结清扫的适宜范围]
Ai Zheng. 2007 Mar;26(3):303-6.
10
[Correlation factors of lymph node metastasis in patients with clinical stage T1a non-small cell lung cancer].[临床分期为T1a的非小细胞肺癌患者淋巴结转移的相关因素]
Zhonghua Zhong Liu Za Zhi. 2015 Apr;37(4):297-300.

引用本文的文献

1
MoLPre: A Machine Learning Model to Predict Metastasis of cT1 Solid Lung Cancer.MoLPre:一种预测cT1期实性肺癌转移的机器学习模型。
Clin Transl Sci. 2025 Apr;18(4):e70186. doi: 10.1111/cts.70186.
2
Development and validation of a nomogram model for predicting lymph node metastasis in early non-small-cell lung cancer.早期非小细胞肺癌淋巴结转移预测列线图模型的构建与验证
Am J Cancer Res. 2025 Jan 15;15(1):299-310. doi: 10.62347/JBKV3746. eCollection 2025.